Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers
Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiangdong Cheng(Hangzhou Cancer Hospital), Xue Wu(Hangzhou Normal University), Yong Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiaohui Pang, Jiani C. Yin(University Health Network), Lingjun Zhu(Henan University), Guojie Xia(Huzhou Central Hospital), Hua Bao, Lin Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yang Shao(Sanya University), Xiaoxi Chen(Soochow University), Minyan Xing(First Affiliated Hospital Zhejiang University)
Cited by 29
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412